DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Heinemann V, Vehling-Kaiser U, Waldschmidt D. et al.
Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the ‘Arbeitsgemeinschaft Internistische Onkologie’ (AIO-PK0104).
Gut 2013;
62: 751-759
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.